TrialNature communications2026

Donor-derived regulatory dendritic cell infusion and early immunosuppressive drug withdrawal in living-donor liver transplantation: a phase I/IIa trial.

Abhinav Humar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.